Adam Johnson

Adam previously worked in experimental and clinical pharmacology of anti-infective agents at the University of Liverpool for 11 years. Focussing on preclinical PK-PD drug development of novel agents.

For his Ph.D. at the University of Liverpool, Adam has been working with novel ß-lactam-ß-lactamase inhibitors, assessing the PK-PD relationship using several in vivo and in vitro infection models.